Trying to learn how to translate from the human translation examples.
From: Machine Translation
Suggest a better translation
Quality:
From professional translators, enterprises, web pages and freely available translation repositories.
lisaks hinnati neerupuudulikkust kombineeritud farmakokineetilises analüüsis.
additionally, renal insufficiency was evaluated in the composite pharmacokinetic analysis.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
farmakokineetilises ja ohutuse profiilis ei täheldatud ohutuse alaseid muutusi.
the pharmacokinetic and safety profiles did not identify any safety concerns.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
farmakokineetilises alamuuringus täheldatud sofosbuviiri ekspositsiooni suurenemine ei oma kliinilist tähtsust.
increase in sofosbuvir exposure observed in the pharmacokinetic substudy is not clinically relevant.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
populatsiooni farmakokineetilises analüüsis ei ilmnenud asenapiini farmakokineetikas sooga seotud erinevusi.
a population pharmacokinetic analysis indicated that there is no evidence of gender-related differences in the pharmacokinetics of asenapine.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
populatsiooni farmakokineetilises analüüsis oli keskmine kliirens vereseerumist 0,0161 l/tunnis.
in the population pk analysis, mean serum clearance was 0.0161 l/hr.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
epilepsiaga patsientide populatsiooni farmakokineetilises analüüsis vähendas perampaneel okskarbasepiini kliirensit 26%.
in the epilepsy population pharmacokinetic analysis, perampanel was found to decrease the clearance of oxcarbazepine by 26%.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
populatsiooni farmakokineetilises analüüsis oli üldbilirubiini suurenenud sisaldus seerumis seotud erlotiniibi aeglasema kliirensiga.
in population pharmacokinetic analysis, increased serum concentrations of total bilirubin were associated with a slower rate of erlotinib clearance.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
omidria hindamise farmakokineetilises uuringus oli süsteemne kokkupuude nii fenüülefriini kui ka ketorolakiga minimaalne ja mööduv.
in a pharmacokinetic study evaluating omidria, systemic exposure to both phenylephrine and ketorolac was minimal and transient.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
lineaarset kliirensit hinnati parameetrina populatsiooni farmakokineetilises analüüsis ning see oli 9,5 ml/h.
the linear clearance was estimated as a parameter in the population pharmacokinetic analysis and was 9.5 ml/h.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
tervetel täiskasvanutel tabletivormi mitmekordsete annustega läbiviidud farmakokineetilises uuringus täheldati neljal osalejal desloratadiini nõrka metaboliseerumist.
in a multiple-dose pharmacokinetic study conducted with the tablet formulation in healthy adult subjects, four subjects were found to be poor metabolisers of desloratadine.
Last Update: 2012-04-11
Usage Frequency: 4
Quality:
eakad farmakokineetilises uuringus tervete eakate vabatahtlikega ei ilmnenud farmakokineetilistes parameetrites olulisi erinevusi, võrreldes nooremate täiskasvanutega.
19 elderly a pharmacokinetic study in elderly healthy volunteers did not show a significant difference in pharmacokinetic parameters compared with younger adults.
Last Update: 2012-04-11
Usage Frequency: 6
Quality:
populatsiooni farmakokineetilises uuringus on siiski näidatud, et vanus ei ole ribaviriini kineetikas oluline; määravaks on neerufunktsioon.
however, in a population pharmacokinetic study, age was not a key factor in the kinetics of ribavirin; renal function is the determining factor.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
arvestades erinevusi farmakokineetilises profiilis ja annustamisskeemis, ei tohi caelyx’it kasutada vaheldumisi teiste doksorubitsiinvesinikkloriidi sisaldavate preparaatidega.
given the difference in pharmacokinetic profiles and dosing schedules, caelyx should not be used interchangeably with other formulations of doxorubicin hydrochloride.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
tavalise sesoonse allergilise riniidi populatsiooniga demograafiliselt võrreldavate patsientidega tehtud farmakokineetilises uuringus saavutas 4 % patsientidest kõrgema desloratadiini kontsentratsiooni.
in a pharmacokinetic trial in which patient demographics were comparable to those of the general seasonal allergic rhinitis population, 4 % of the subjects achieved a higher concentration of desloratadine.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
uuringu engage af-timi 48 populatsiooni farmakokineetilises analüüsis olid maksimaalne ja üldine kontsentratsioon asiaatidest ja mitte-asiaatidest patsientidel võrreldavad.
in a population pharmacokinetic analysis of the engage af-timi 48 study, peak and total exposure in asian patients and non-asian patients were comparable.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
farmakokineetilises uuringus eritusid ivakaftoor ja selle metaboliidid minimaalselt uriiniga (uriiniga väljus ainult 6,6% kogu radioaktiivsusest).
in a human pharmacokinetic study, there was minimal elimination of ivacaftor and its metabolites in urine (only 6.6% of total radioactivity was recovered in the urine).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
populatsiooni farmakokineetilises analüüsis ilmnes meestel 17% suurem kliirens (cl/f) ja 48% suurem jaotusruumala (v/f) kui naistel.
the population pharmacokinetic analysis indicated a 17% greater apparent clearance (cl/f) and a 48% greater apparent volume of distribution (v/f) in males than in females.
Last Update: 2017-04-26
Usage Frequency: 1
Quality: